{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:45:31Z","timestamp":1792813531956,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High-Level Hospital Clinical Research Funding","award":["BJ-2024-183"],"award-info":[{"award-number":["BJ-2024-183"]}]},{"name":"National High-Level Hospital Clinical Research Funding","award":["BJ-2023-067"],"award-info":[{"award-number":["BJ-2023-067"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01291-1","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:17:18Z","timestamp":1770801438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Free water in the external globus pallidus predicts mild cognitive impairment in Parkinson\u2019s disease and is associated with serum neurofilament light chain levels"],"prefix":"10.1038","volume":"12","author":[{"given":"Huimin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"1291_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/mds.27902","volume":"35","author":"C Baiano","year":"2020","unstructured":"Baiano, C., Barone, P., Trojano, L. & Santangelo, G. Prevalence and clinical aspects of mild cognitive impairment in Parkinson\u2019s disease: a meta-analysis. Mov. Disord. 35, 45\u201354 (2020).","journal-title":"Mov. Disord."},{"key":"1291_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/archneur.60.3.387","volume":"60","author":"D Aarsland","year":"2003","unstructured":"Aarsland, D., Andersen, K., Larsen, J. P., Lolk, A. & Kragh-Sorensen, P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 60, 387\u2013392 (2003).","journal-title":"Arch. Neurol."},{"key":"1291_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1093\/brain\/awy072","volume":"141","author":"J Schulz","year":"2018","unstructured":"Schulz, J., Pagano, G., Fernandez Bonfante, J. A., Wilson, H. & Politis, M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain 141, 1501\u20131516 (2018).","journal-title":"Brain"},{"key":"1291_CR4","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/mds.30023","volume":"39","author":"NM Slater","year":"2024","unstructured":"Slater, N. M., Melzer, T. R., Myall, D. J., Anderson, T. J. & Dalrymple-Alford, J. C. Cholinergic basal forebrain integrity and cognition in Parkinson\u2019s disease: a reappraisal of magnetic resonance imaging evidence. Mov. Disord. 39, 2155\u20132172 (2024).","journal-title":"Mov. Disord."},{"key":"1291_CR5","doi-asserted-by":"publisher","first-page":"106243","DOI":"10.1016\/j.nbd.2023.106243","volume":"185","author":"RA Crockett","year":"2023","unstructured":"Crockett, R. A., Wilkins, K. B., Aditham, S. & Bronte-Stewart, H. M. No laughing white matter: reduced integrity of the cortical cholinergic pathways in Parkinson\u2019s disease-related cognitive impairment. Neurobiol. Dis. 185, 106243 (2023).","journal-title":"Neurobiol. Dis."},{"key":"1291_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s00415-025-13201-1","volume":"272","author":"V Sumra","year":"2025","unstructured":"Sumra, V. et al. Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration. J. Neurol. 272, 478 (2025).","journal-title":"J. Neurol."},{"key":"1291_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.neurobiolaging.2014.10.029","volume":"36","author":"E Ofori","year":"2015","unstructured":"Ofori, E. et al. Increased free water in the substantia nigra of Parkinson\u2019s disease: a single-site and multi-site study. Neurobiol. Aging 36, 1097\u20131104 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1291_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/brain\/awac127","volume":"146","author":"NJ Ray","year":"2023","unstructured":"Ray, N. J. et al. Free-water imaging of the cholinergic basal forebrain and pedunculopontine nucleus in Parkinson\u2019s disease. Brain 146, 1053\u20131064 (2023).","journal-title":"Brain"},{"key":"1291_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209220","volume":"102","author":"D Zhang","year":"2024","unstructured":"Zhang, D. et al. Free-water imaging of the nucleus basalis of Meynert in patients with idiopathic REM sleep behavior disorder and Parkinson disease. Neurology 102, e209220 (2024).","journal-title":"Neurology"},{"key":"1291_CR10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen, N. I. et al. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol. 72, 194\u2013200 (2015).","journal-title":"JAMA Neurol."},{"key":"1291_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56660-w","volume":"16","author":"B Lee","year":"2025","unstructured":"Lee, B. et al. Dopaminergic modulation and dosage effects on brain state dynamics and working memory component processes in Parkinson\u2019s disease. Nat. Commun. 16, 2433 (2025).","journal-title":"Nat. Commun."},{"key":"1291_CR12","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/mds.26051","volume":"29","author":"FJ Siepel","year":"2014","unstructured":"Siepel, F. J. et al. Cognitive executive impairment and dopaminergic deficits in de novo Parkinson\u2019s disease. Mov. Disord. 29, 1802\u20131808 (2014).","journal-title":"Mov. Disord."},{"key":"1291_CR13","doi-asserted-by":"publisher","first-page":"16183","DOI":"10.18632\/aging.103628","volume":"12","author":"X Jia","year":"2020","unstructured":"Jia, X. et al. Differential functional dysconnectivity of caudate nucleus subdivisions in Parkinson\u2019s disease. Aging (Albany, NY) 12, 16183\u201316194 (2020).","journal-title":"Aging (Albany, NY)"},{"key":"1291_CR14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138","author":"J Gratwicke","year":"2015","unstructured":"Gratwicke, J., Jahanshahi, M. & Foltynie, T. Parkinson\u2019s disease dementia: a neural networks perspective. Brain 138, 1454\u20131476 (2015).","journal-title":"Brain"},{"key":"1291_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000213623","volume":"104","author":"E Benarroch","year":"2025","unstructured":"Benarroch, E. What are current concepts on the functional organization of the globus pallidus externus and its potential role in Parkinson disease? Neurology 104, e213623 (2025).","journal-title":"Neurology"},{"key":"1291_CR16","doi-asserted-by":"publisher","first-page":"645287","DOI":"10.3389\/fncir.2021.645287","volume":"15","author":"J Dong","year":"2021","unstructured":"Dong, J., Hawes, S., Wu, J., Le, W. & Cai, H. Connectivity and functionality of the globus pallidus externa under normal conditions and Parkinson\u2019s disease. Front. Neural Circuits 15, 645287 (2021).","journal-title":"Front. Neural Circuits"},{"key":"1291_CR17","doi-asserted-by":"crossref","unstructured":"Kubota, H., Zhou, X., Zhang, X., Watanabe, H. & Nagai, T. Pramipexole hyperactivates the external globus pallidus and impairs decision-making in a mouse model of Parkinson\u2019s disease. Int. J. Mol. Sci. 25, 8849 (2024).","DOI":"10.3390\/ijms25168849"},{"key":"1291_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","volume":"88","author":"KF Pedersen","year":"2017","unstructured":"Pedersen, K. F., Larsen, J. P., Tysnes, O. B. & Alves, G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88, 767\u2013774 (2017).","journal-title":"Neurology"},{"key":"1291_CR19","doi-asserted-by":"publisher","first-page":"1598974","DOI":"10.3389\/fneur.2025.1598974","volume":"16","author":"YD Liu","year":"2025","unstructured":"Liu, Y. D. et al. Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson\u2019s disease. Front. Neurol. 16, 1598974 (2025).","journal-title":"Front. Neurol."},{"key":"1291_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/NRE-218001","volume":"48","author":"T Loetscher","year":"2021","unstructured":"Loetscher, T. Cognitive training interventions for dementia and mild cognitive impairment in Parkinson\u2019s disease\u2014a cochrane review summary with commentary. NeuroRehabilitation 48, 385\u2013387 (2021).","journal-title":"NeuroRehabilitation"},{"key":"1291_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/mds.26236","volume":"30","author":"E Mamikonyan","year":"2015","unstructured":"Mamikonyan, E., Xie, S. X., Melvin, E. & Weintraub, D. Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study. Mov. Disord. 30, 912\u2013918 (2015).","journal-title":"Mov. Disord."},{"key":"1291_CR22","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.26617","volume":"31","author":"D Weintraub","year":"2016","unstructured":"Weintraub, D. et al. Rasagiline for mild cognitive impairment in Parkinson\u2019s disease: a placebo-controlled trial. Mov. Disord. 31, 709\u2013714 (2016).","journal-title":"Mov. Disord."},{"key":"1291_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake, M. et al. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain 136, 1128\u20131138 (2013).","journal-title":"Brain"},{"key":"1291_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","volume":"41","author":"F Giovannoni","year":"2020","unstructured":"Giovannoni, F. & Quintana, F. J. The role of astrocytes in CNS inflammation. Trends Immunol. 41, 805\u2013819 (2020).","journal-title":"Trends Immunol."},{"key":"1291_CR25","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1002\/acn3.51234","volume":"7","author":"C Barro","year":"2020","unstructured":"Barro, C., Chitnis, T. & Weiner, H. L. Blood neurofilament light: a critical review of its application to neurologic disease. Ann. Clin. Transl. Neurol. 7, 2508\u20132523 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1291_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/WNL.0000000000010346","volume":"95","author":"R Kapoor","year":"2020","unstructured":"Kapoor, R. et al. Serum neurofilament light as a biomarker in progressive multiple sclerosis. Neurology 95, 436\u2013444 (2020).","journal-title":"Neurology"},{"key":"1291_CR27","doi-asserted-by":"publisher","first-page":"e000958","DOI":"10.1136\/bmjmed-2024-000958","volume":"4","author":"MR Turner","year":"2025","unstructured":"Turner, M. R., Thompson, A. G. & Teunissen, C. E. Blood level of neurofilament light chain as a biomarker for neurological disorders. BMJ Med. 4, e000958 (2025).","journal-title":"BMJ Med."},{"key":"1291_CR28","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/mds.28779","volume":"36","author":"WW Aamodt","year":"2021","unstructured":"Aamodt, W. W. et al. Neurofilament light chain as a biomarker for cognitive decline in Parkinson disease. Mov. Disord. 36, 2945\u20132950 (2021).","journal-title":"Mov. Disord."},{"key":"1291_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41531-022-00384-x","volume":"8","author":"L Batzu","year":"2022","unstructured":"Batzu, L. et al. Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 154 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1291_CR30","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1002\/hbm.24760","volume":"40","author":"T Mitchell","year":"2019","unstructured":"Mitchell, T. et al. Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism. Hum. Brain Mapp. 40, 5094\u20135107 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"1291_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.parkreldis.2022.01.002","volume":"95","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. Perivascular space in Parkinson\u2019s disease: association with CSF amyloid\/tau and cognitive decline. Parkinsonism Relat. Disord. 95, 70\u201376 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1291_CR32","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.25811","volume":"88","author":"DJ Irwin","year":"2020","unstructured":"Irwin, D. J. et al. Evolution of Alzheimer\u2019s disease cerebrospinal fluid biomarkers in early Parkinson\u2019s disease. Ann. Neurol. 88, 574\u2013587 (2020).","journal-title":"Ann. Neurol."},{"key":"1291_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-023-02570-4","volume":"146","author":"L Yu","year":"2023","unstructured":"Yu, L. et al. Plasma p-tau181 and p-tau217 in discriminating PART, AD and other key neuropathologies in older adults. Acta Neuropathol. 146, 1\u201311 (2023).","journal-title":"Acta Neuropathol."},{"key":"1291_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"1291_CR35","doi-asserted-by":"publisher","first-page":"106887","DOI":"10.1016\/j.nbd.2025.106887","volume":"208","author":"YT Yuan","year":"2025","unstructured":"Yuan, Y. T., Hong, W. P., Tan, C. H. & Yu, R. L. Influence of WWOX\/MAF genes on cognitive performance in patients with Parkinson\u2019s disease. Neurobiol. Dis. 208, 106887 (2025).","journal-title":"Neurobiol. Dis."},{"key":"1291_CR36","doi-asserted-by":"publisher","first-page":"246.e18","DOI":"10.1111\/ene.13797","volume":"26","author":"LM Chahine","year":"2019","unstructured":"Chahine, L. M. et al. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson\u2019s disease. Eur. J. Neurol. 26, 246.e18 (2019).","journal-title":"Eur. J. Neurol."},{"key":"1291_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.exger.2018.11.020","volume":"115","author":"S Guzzetti","year":"2019","unstructured":"Guzzetti, S., Mancini, F., Caporali, A., Manfredi, L. & Daini, R. The association of cognitive reserve with motor and cognitive functions for different stages of Parkinson\u2019s disease. Exp. Gerontol. 115, 79\u201387 (2019).","journal-title":"Exp. Gerontol."},{"key":"1291_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker, I","year":"2011","unstructured":"Parkinson Progression Marker, I The Parkinson Progression Marker Initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"1291_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord."},{"key":"1291_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(16)30328-3","volume":"16","author":"A Schrag","year":"2017","unstructured":"Schrag, A., Siddiqui, U. F., Anastasiou, Z., Weintraub, D. & Schott, J. M. Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson\u2019s disease: a cohort study. Lancet Neurol. 16, 66\u201375 (2017).","journal-title":"Lancet Neurol."},{"key":"1291_CR41","doi-asserted-by":"publisher","first-page":"703158","DOI":"10.3389\/fnagi.2021.703158","volume":"13","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Development and validation of a prognostic model for cognitive impairment in Parkinson\u2019s disease with REM sleep behavior disorder. Front. Aging Neurosci. 13, 703158 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1291_CR42","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer, B. et al. Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov. Disord. 35, 1999\u20132008 (2020).","journal-title":"Mov. Disord."},{"key":"1291_CR43","doi-asserted-by":"publisher","first-page":"116137","DOI":"10.1016\/j.neuroimage.2019.116137","volume":"202","author":"JD Tournier","year":"2019","unstructured":"Tournier, J. D. et al. MRtrix3: a fast, flexible and open software framework for medical image processing and visualisation. Neuroimage 202, 116137 (2019).","journal-title":"Neuroimage"},{"key":"1291_CR44","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mrm.22055","volume":"62","author":"O Pasternak","year":"2009","unstructured":"Pasternak, O., Sochen, N., Gur, Y., Intrator, N. & Assaf, Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med. 62, 717\u2013730 (2009).","journal-title":"Magn. Reson. Med."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01291-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01291-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:01:42Z","timestamp":1774008102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01291-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1291"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01291-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}